ALNY icon

Alnylam Pharmaceuticals
ALNY

Overview Fund Activity

254 hedge funds and large institutions have $4.42B invested in Alnylam Pharmaceuticals in 2016 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 113 increasing their positions, 63 reducing their positions, and 36 closing their positions.

Holders
254
Holders Change
-6
Holders Change %
-2.31%
% of All Funds
6.78%
Holding in Top 10
9
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+28.57%
% of All Funds
0.24%
New
33
Increased
113
Reduced
63
Closed
36
Calls
$56.3M
Puts
$50.9M
Net Calls
+$5.36M
Net Calls Change
+$9.76M

Top Buyers

1
Wellington Management Group
1
Wellington Management Group
Massachusetts
$750M
2
VAM
2
Visium Asset Management
New York
$49.7M
3
Baillie Gifford & Co
3
Baillie Gifford & Co
United Kingdom
$212M
4
Citadel Advisors
4
Citadel Advisors
Florida
$45.9M
5
SPC
5
Slate Path Capital
New York
$71.2M

Top Sellers

1
First Trust Advisors
1
First Trust Advisors
Illinois
$28.9M
2
Jennison Associates
2
Jennison Associates
New York
$60.9M
3
UBS AM
3
UBS AM
Illinois
$104M
4
Invesco
4
Invesco
Georgia
$8.19M
5
AQR Capital Management
5
AQR Capital Management
Connecticut
$235K
Name Market Value Shares Shares
Change 		Shares
Change %
Fidelity Investments
1
Fidelity Investments
Massachusetts
$804M 12,803,295 +92,939 +0.7%
Wellington Management Group
2
Wellington Management Group
Massachusetts
$750M 11,945,607 +1,288,123 +12%
Vanguard Group
3
Vanguard Group
Pennsylvania
$327M 5,202,895 +154,674 +3%
Baillie Gifford & Co
4
Baillie Gifford & Co
United Kingdom
$212M 3,379,935 +652,201 +24%
Capital World Investors
5
Capital World Investors
California
$122M 1,938,603 – –
State Street
6
State Street
Massachusetts
$122M 1,936,520 +262,783 +16%
BFA
7
BlackRock Fund Advisors
California
$115M 1,838,376 +112,252 +7%
BIT
8
BlackRock Institutional Trust
California
$112M 1,776,659 +3,770 +0.2%
UBS AM
9
UBS AM
Illinois
$104M 1,651,923 -269,353 -14%
GGHC
10
Gilder Gagnon Howe & Co
New York
$88.8M 1,414,631 -62,736 -4%
T. Rowe Price Associates
11
T. Rowe Price Associates
Maryland
$80.6M 1,284,082 +46,237 +4%
BB
12
BB Biotech
Switzerland
$74.8M 1,191,338 +58,839 +5%
SPC
13
Slate Path Capital
New York
$71.2M 1,135,000 +410,000 +57%
Morgan Stanley
14
Morgan Stanley
New York
$67.7M 1,078,882 -18,043 -2%
BRC
15
Blue Ridge Capital
New York
$67.5M 1,075,000 – –
Jennison Associates
16
Jennison Associates
New York
$60.9M 970,453 -519,088 -35%
Franklin Resources
17
Franklin Resources
California
$59.2M 943,723 -24,102 -2%
RI
18
RTW Investments
New York
$54.4M 866,379 +293,018 +51%
BM
19
Bridger Management
New York
$50M 797,212 +79,691 +11%
VAM
20
Visium Asset Management
New York
$49.7M 792,295 +690,948 +682%
Wells Fargo
21
Wells Fargo
California
$48.5M 773,051 -1,185 -0.2%
Citadel Advisors
22
Citadel Advisors
Florida
$45.9M 730,736 +549,198 +303%
1WCM
23
12 West Capital Management
New York
$43.7M 696,000 +45,000 +7%
Goldman Sachs
24
Goldman Sachs
New York
$40.3M 641,874 +248,739 +63%
AG
25
Artal Group
Luxembourg
$37.7M 600,000 +125,000 +26%
1
2 3 4 5